Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The pleckstrin homology domain-containing family A member 8 (PLEKHA8, commonly known as FAPP2) is an essential lipid-transfer and adaptor protein predominantly localized at the trans-Golgi network and nucleoplasm[1][2][3]. PLEKHA8 binds phosphatidylinositol 4-phosphate via its pleckstrin homology domain and facilitates vesicle generation and fission, ensuring proper trafficking of apical cargo in polarized cells. It couples lipid transfer activity with glycosphingolipid metabolism, delivering glucosylceramide from ER to the plasma membrane. PLEKHA8 is involved in ciliogenesis and maintenance of membrane identity. Altered expression of PLEKHA8 impacts cell survival, proliferation, and has been implicated in cancer progression (where downregulation sensitizes cells to apoptosis), pregnancy disorders (via miRNA-mediated repression), and neurodevelopmental disorders such as autism spectrum disorder (where rare variants confer genetic risk)[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pleckstrin homology domain-containing family A member 8 (PLEKHA8).